Related references
Note: Only part of the references are listed.A Multicenter, Double-Blind Trial of a High-Dose Caspofungin Treatment Regimen versus a Standard Caspofungin Treatment Regimen for Adult Patients with Invasive Candidiasis
Robert F. Betts et al.
CLINICAL INFECTIOUS DISEASES (2009)
Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2009)
INTRAVITREAL VORICONAZOLE In Vitro Safety-Profile for Fungal Endophthalmitis
Marcus Kernt et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2009)
Cerebrospinal Fluid and Plasma (1→3)-β-D-Glucan as Surrogate Markers for Detection and Monitoring of Therapeutic Response in Experimental Hematogenous Candida Meningoencephalitis
Ruta Petraitiene et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Voriconazole in the treatment of fungal eye infections: a review of current literature
S. M. Hariprasad et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2008)
Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes
Andres Pascual et al.
CLINICAL INFECTIOUS DISEASES (2008)
Treatment of aspergillosis: Clinical practice guidelines of the infectious diseases society of America
Thomas J. Walsh et al.
CLINICAL INFECTIOUS DISEASES (2008)
Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2007)
Anidulafungin versus fluconazole for invasive candidiasis
Annette C. Reboli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Ocular penetration of caspofungin in a rabbit uveitis model
David Goldblum et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2007)
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial
Ernst-Ruediger Kuse et al.
LANCET (2007)
Clearance of intravitreal voriconazole
Ying-Cheng Shen et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
Successful treatment of resistant ocular fusariosis with posaconazole (SCH-56592)
Elmer Y. Tu et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2007)
Intravitreal voriconazole for the treatment of endogenous Aspergillus endophthalmitis
M Kramer et al.
OPHTHALMOLOGY (2006)
Voriconazole therapeutic drug monitoring
J Smith et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Treatment outcomes after pars plana vitrectomy for endogenous endophthalmitis
Yan-Qiong Zhang et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2005)
Subtherapeutic ocular penetration of caspofungin and associated treatment failure in Candida albicans endophthalmitis
GM Gauthier et al.
CLINICAL INFECTIOUS DISEASES (2005)
Candida glabrata endophthalmitis treated successfully with caspofungin
JC Sarria et al.
CLINICAL INFECTIOUS DISEASES (2005)
Retinal function assessed by ERG before and after induction of ocular aspergillosis and treatment by the anti-fungal, micafungin, in rabbits
JM Harrison et al.
DOCUMENTA OPHTHALMOLOGICA (2005)
Management of endogenous fungal endophthalmitis with voriconazole and caspofungin
SM Breit et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2005)
Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans
SM Hariprasad et al.
ARCHIVES OF OPHTHALMOLOGY (2004)
Intravitreal voriconazole - An electroretinographic and histopathologic study
H Gao et al.
ARCHIVES OF OPHTHALMOLOGY (2004)
Comparative toxicity and concentrations of intravitreal amphotericin B formulations in a rabbit model
JP Cannon et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
Comparison of caspofungin and amphotericin B for invasive candidiasis.
J Mora-Duarte et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Ocular distribution of intravenously administered lipid formulations of amphotericin B in a rabbit model
D Goldblum et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Endogenous Aspergillus endophthalmitis -: Report of 3 cases and review of the literature
J Riddell et al.
MEDICINE (2002)
Do climatic variables influence the development of posterior vitreous detachment?
R Rahman et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2002)
Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits
V Petraitis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Compartmental pharmacokinetics and tissue distribution of the antifungal echinocandin lipopeptide micafungin (FK463) in rabbits
AH Groll et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): Reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma sampling
AH Groll et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Compartmental pharmacokinetics of the antifungal echinocandin caspofungin (MK-0991) in rabbits
AH Groll et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Share Paper
